Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 470.75 INR
Change Today -14.55 / -3.00%
Volume 507.9K
As of 7:05 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

alembic pharmaceuticals ltd (ALPM) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/23/15 - 510.00
52 Week Low
05/19/14 - 227.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

alembic pharmaceuticals ltd (ALPM) Related Businessweek News

No Related Businessweek News Found

alembic pharmaceuticals ltd (ALPM) Details

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and Intermediates in India and internationally. The company operates in three segments: International Generics, Branded Formulations, and Active Pharmaceutical Ingredients. It offers active pharmaceutical ingredients for anti-infective, cardio-vascular, musculoskeletal, erectile dysfunction, and gastro-intestinal products. The company also provides bulk pharma chemicals, including phosgene gas and phosgene based specialty chemicals/intermediates for use in pesticides, pharmaceuticals, dyes, plastics, perfumeries, etc.; and drug intermediates, specialty chemicals, and fine chemicals, as well as is engaged in contract manufacturing and custom synthesis activities. In addition, it offers finished dosage formulations for various therapeutic areas, including anti-infective, cough and cold, cardiovascular, and oral anti-diabetics; herbal nutraceuticals; veterinary products; and contract/collaborated research services. The company was founded in 1907 and is headquartered in Vadodara, India.

Founded in 1907

alembic pharmaceuticals ltd (ALPM) Top Compensated Officers

Chairman and Managing Director
Total Annual Compensation: 30.0M
Chief Financial Officer, Director of Finance ...
Total Annual Compensation: 19.5M
President of International Business, Executiv...
Total Annual Compensation: 34.6M
President of Branded Formulations Business an...
Total Annual Compensation: 33.8M
Compensation as of Fiscal Year 2014.

alembic pharmaceuticals ltd (ALPM) Key Developments

Alembic Pharmaceuticals Limited, 2015 Earnings Call, Apr 27, 2015

Alembic Pharmaceuticals Limited, 2015 Earnings Call, Apr 27, 2015

Alembic Pharmaceuticals Limited to Report Fiscal Year 2015 Results on Apr 27, 2015

Alembic Pharmaceuticals Limited announced that they will report fiscal year 2015 results on Apr 27, 2015

Alembic Pharmaceuticals Limited, Board Meeting, Apr 27, 2015

Alembic Pharmaceuticals Limited, Board Meeting, Apr 27, 2015. Agenda: To consider and approve audited financial results of the company for the financial year ended March 31, 2015; and to consider and recommend dividend on equity shares, if any, for the financial year ended March 31, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALPM:IN 470.75 INR -14.55

ALPM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALPM.
View Industry Companies

Industry Analysis


Industry Average

Valuation ALPM Industry Range
Price/Earnings 33.1x
Price/Sales 4.5x
Price/Book 11.1x
Price/Cash Flow 28.5x
TEV/Sales 4.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEMBIC PHARMACEUTICALS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at